Live Market Updates
Latest Financial News
Stay ahead with real-time financial news, market insights, and expert analysis from trusted sources worldwide
News Feed
1 articles
Live Market Updates
Latest Financial News
Stay ahead with real-time financial news, market insights, and expert analysis from trusted sources worldwide
positive
5h agoPanacea Biotec Secures Govt Order for Bivalent Oral Polio Vaccine Worth ₹127.20 Crore
Panacea Biotec received a letter of acceptance from the Ministry of Health & Family Welfare to supply bivalent oral polio vaccine (bOPV) valued at ₹127.20 crore. The contract includes phased deliveries over 90 to 480 days, supporting India’s ongoing immunization initiatives under the Universal Immunization Programme. Analysts said the order reinforces Biotec’s position in the public health supply chain and highlights continued government focus on disease eradication and vaccine accessibility.
positive
5h agoPanacea Biotec Secures Govt Order for Bivalent Oral Polio Vaccine Worth ₹127.20 Crore
Panacea Biotec received a letter of acceptance from the Ministry of Health & Family Welfare to supply bivalent oral polio vaccine (bOPV) valued at ₹127.20 crore. The contract includes phased deliveries over 90 to 480 days, supporting India’s ongoing immunization initiatives under the Universal Immunization Programme. Analysts said the order reinforces Biotec’s position in the public health supply chain and highlights continued government focus on disease eradication and vaccine accessibility.
Breaking
positive
Panacea Biotec Secures Govt Order for Bivalent Oral Polio Vaccine Worth ₹127.20 Crore
about 5 hours ago
1 min read
70 words
Contract secures critical government order bolstering pharma segment revenues.
Panacea Biotec received a letter of acceptance from the Ministry of Health & Family Welfare to supply bivalent oral polio vaccine (bOPV) valued at ₹127.20 crore. The contract includes phased deliveries over 90 to 480 days, supporting India’s ongoing immunization initiatives under the Universal Immunization Programme. Analysts said the order reinforces Biotec’s position in the public health supply chain and highlights continued government focus on disease eradication and vaccine accessibility.
Panacea Biotec received a letter of acceptance from the Ministry of Health & Family Welfare to supply bivalent oral polio vaccine (bOPV) valued at ₹127.20 crore. The contract includes phased deliveries over 90 to 480 days, supporting India’s ongoing immunization initiatives under the Universal Immunization Programme. Analysts said the order reinforces Biotec’s position in the public health supply chain and highlights continued government focus on disease eradication and vaccine accessibility.
Companies:
Panacea Biotec
Tags:
Panacea Biotec
vaccine supply
Panacea Biotec
vaccine supply
public health
bOPV
pharma orders
Source: